139 Results for "

PPAR-delta

" in MedChemExpress (MCE) Product Catalog:
Products (139)

139 Results for "PPAR-delta" in MCE Product Catalog:

223
223 Publications Verification
Cat. No.: HY-16578
CAS No.: 22978-25-2
Target:  

PPAR

Research Areas:  

Cancer

GW9662 is a potent and selective PPARγ antagonist with an IC50 of 3.3 nM, showing 10 and 1000-fold selectivity over PPARα and PPARδ, respectively.
loading...
    loading...
146
146 Cited Publications
Cat. No.: HY-14649
CAS No.: 302-79-4
Purity:  99.81%
Synonyms: Vitamin A acid; all-trans-Retinoic acid; ATRA
Retinoic acid is a metabolite of vitamin A that plays important roles in cell growth, differentiation, and organogenesis. Retinoic acid is a natural agonist of RAR nuclear receptors, with IC50s of 14 nM for RARα/β/γ. Retinoic acid bind to PPARβ/δ with Kd of 17 nM. Retinoic acid acts as an inhibitor of transcription factor Nrf2 through activation of retinoic acid receptor alpha.
loading...
    loading...
38
38 Cited Publications
Cat. No.: HY-16995
CAS No.: 50892-23-4
Synonyms: Wy-14643
Target:  

PPAR

Pirinixic acid (Wy-14643) is a potent agonist of PPARα, with EC50s of 0.63 μM, 32 μM for murine PPARα and PPARγ, and 5.0 μM, 60 μM, 35 μM for human PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
29
29 Cited Publications
Cat. No.: HY-10838
CAS No.: 317318-70-0
Purity:  99.27%
Synonyms: GW 1516; GSK-516
Target:  

PPAR Autophagy

Research Areas:  

Metabolic Disease Cancer

GW 501516 (GW 1516) is a PPARδ agonist with an EC50 of 1.1 nM .
loading...
    loading...
25
25 Cited Publications
Cat. No.: HY-13861
CAS No.: 265129-71-3
Purity:  99.45%
Target:  

PPAR

Research Areas:  

Cardiovascular Disease

GW7647 is a potent PPARα agonist, with EC50s of 6 nM, 1.1 μM, and 6.2 μM for human PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
18
18 Cited Publications
Cat. No.: HY-13928
CAS No.: 317318-84-6
Purity:  99.94%
Synonyms: GW610742
GW0742 is a potent PPARβ and PPARδ agonist, with an IC50 of 1 nM for human PPARδ in binding assay, and EC50s of 1 nM, 1.1 μM and 2 μM for human PPARδ, PPARα, and PPARγ, respectively.
loading...
    loading...
17
17 Cited Publications
Cat. No.: HY-15577
CAS No.: 188591-46-0
Purity:  98.11%
Target:  

PPAR

Research Areas:  

Cancer

GSK3787 is a selective and irreversible peroxisome proliferator-activated receptor δ (PPARδ) antagonist with pIC50 of 6.6.
loading...
    loading...
16
16 Cited Publications
Cat. No.: HY-16737
CAS No.: 923978-27-2
Synonyms: GFT505
Target:  

PPAR

Elafibranor (GFT505) is a PPARα/δ agonist with EC50s of 45 and 175 nM, respectively. Elafibranor can be used for the study of primary biliary cholangitis .
loading...
    loading...
14
14 Cited Publications
Cat. No.: HY-B0637
CAS No.: 41859-67-0
Synonyms: BM15075
Target:  

PPAR

Bezafibrate is an agonist of PPAR, with EC50s of 50 μM, 60 μM, 20 μM for human PPARα, PPARγ and PPARδ, and 90 μM, 55 μM, 110 μM for murine PPARα, PPARγ and PPARδ, respectively; Bezafibrate is used as an hypolipidemic agent.
loading...
    loading...
10
10 Cited Publications
Cat. No.: HY-N0234
CAS No.: 19879-30-2
Synonyms: 7-O-Methylbavachin; Bavachinin A
Bavachinin is agonist of pan-peroxisome proliferator-activated receptor (PPAR), with the IC50 value of 21.043 μM, 12.819 μM, and 0.622 μM to PPAR-α, RRAR-β/δ, and PPAR-γ, respectively. Bavachinin is an inhibitor of HIF-1α. Bavachinin exhibits antitumor activity against non-small cell lung cancer by targeting RRAR-γ. Bavachinin is a natural compound with anti-inflammatory and anti-angiogenic activities. Bavachinin has orally bioactivity. .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-114263
CAS No.: 1454925-59-7
Purity:  99.07%
Target:  

PPAR

Research Areas:  

Cancer

NXT629 is a potent, selective, and competitive PPAR-α antagonist, with an IC50 of 77 nM for human PPARα, shows high selectivity over other nuclear hormone receptor, such as PPARδ, PPARγ, ERβ, GR and TRβ, IC50s are 6.0, 15, 15.2, 32.5 and >100 μM, respectively . NXT629 has potent anti-tumor activity and inhibits experimental metastasis of cancer cell in animal models .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-112813
CAS No.: 2247372-59-2
Purity:  99.42%
Research Areas:  

Metabolic Disease

TUG-1375 is an agonist of free fatty acid receptor 2 (FFA2/GPR43), with a pKi of 6.69. TUG-1375 is inactive on FFA3, FFA4, PPARα, PPARγ, PPARδ, LXRα or LXRβ .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-113081
CAS No.: 15763-06-1
Purity:  99.21%
1-Methyladenosine is an RNA modification that can serve as a tumor marker, with elevated levels in the body associated with cancer development. Following 1-methyladenosine methylation, upregulation of PPARδ expression regulates cholesterol metabolism and activates Hedgehog signaling pathway, driving liver tumorigenesis .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108568
CAS No.: 87893-55-8
Purity:  97.50%
Synonyms: 15d-PGJ2; 15-Deoxy-Δ12,14-PGJ2
15-Deoxy-Δ-12,14-prostaglandin J2 (15d-PGJ2) is a cyclopentenone prostaglandin and a metabolite of PGD2. 15-Deoxy-Δ-12,14-prostaglandin J2 is a selective PPARγ (EC50 of 2 µM) and a covalent PPARδ agonist. 15-Deoxy-Δ-12,14-prostaglandin J2 promotes efficient differentiation of C3H10T1/2 fibroblasts to adipocytes with an EC50 of 7 μM .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-B0760
CAS No.: 42017-89-0
Synonyms: FNF acid
Target:  

PPAR COX

Research Areas:  

Metabolic Disease

Fenofibric acid, an active metabolite of fenofibrate, is a PPAR activitor, with EC50s of 22.4 μM, 1.47 μM, and 1.06 μM for PPARα, PPARγ and PPARδ, respectively; Fenofibric acid also inhibits COX-2 enzyme activity, with an IC50 of 48 nM.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-20019
CAS No.: 79558-09-1
Target:  

PPAR

Research Areas:  

Metabolic Disease

L-165041 is a cell permeable PPARδ agonist, with Kis of 6 nM and appr 730 nM for PPARδ and PPARγ, respectively, and induces adipocyte differentiation in NIH-PPARδ cells.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-106278
CAS No.: 343321-96-0
Purity:  99.44%
Target:  

PPAR

Research Areas:  

Metabolic Disease

GW 590735 is a potent and selective PPARα agonist. GW 590735 showsEC50=4 nM on PPARα and at least 500-fold selectivity versus PPARδ and PPARγ. GW 590735 can be used for the research of dyslipidemia .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19522
CAS No.: 851528-79-5
Synonyms: MBX-8025; RWJ-800025
Target:  

PPAR

Research Areas:  

Metabolic Disease

Seladelpar (MBX-8025) is an orally active, potent and specific PPARδ agonist with an EC50 of 2 nM. Seladelpar shows more than 750-fold and 2500-fold selectivity over the PPARα and PPARγ receptors, respectively. Seladelpar can be used for the study of primary biliary cholangitis .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-106266
CAS No.: 743438-45-1
Purity:  99.81%
Synonyms: Carfloglitazar
Target:  

PPAR

Research Areas:  

Metabolic Disease

Chiglitazar (Carfloglitazar) is a PPARα/γ dual agonist, with EC50s of 1.2, 0.08, 1.7 μM for PPARα, PPARγ and PPARδ, respectively.
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-19737A
CAS No.: 1361504-77-9
Target:  

PPAR

Research Areas:  

Cancer

DG172 dihydrochloride is a selective PPARβ/δ antagonist, with an IC50 of 27 nM.
loading...
    loading...